1. AB0497 Six cases of macrophage activation syndrome as presenting manifestation of systemic lupus erythematosus. (15th June 2017) Authors: Dall'ara, F; Cavazzana, I; Frassi, M; Taraborelli, M; Fredi, M; Franceschini, F; Andreoli, L; Tincani, A; Airò, P Journal: Annals of the rheumatic diseases Issue: Volume 76(2017)Supplement 2 Page Start: 1225 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Anti-MIT3 antibodies in systemic sclerosis. (22nd February 2011) Authors: Cavazzana, I; Taraborelli, M; Ceribelli, A; Fredi, M; Norman, G; Satoh, M; Franceschini, F Journal: Annals of the rheumatic diseases Issue: Volume 70(2011)Supplement 2 Page Start: A84 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. FRI0261 Skin cancer in a cohort of systemic lupus erythematosus. (15th June 2017) Authors: Taraborelli, M; Genitori, C; Cavazzana, I; Fredi, M; Tincani, A; Pinton, P Calzavara; Franceschini, F Journal: Annals of the rheumatic diseases Issue: Volume 76(2017)Supplement 2 Page Start: 585 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Organ damage accrual and distribution in systemic lupus erythematosus patients followed-up for more than 10 years. (October 2017) Authors: Taraborelli, M; Cavazzana, I; Martinazzi, N; Lazzaroni, M Grazia; Fredi, M; Andreoli, L; Franceschini, F; Tincani, A Journal: Lupus Issue: Volume 26:Number 11(2017) Page Start: 1197 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Patients with longstanding primary antiphospholipid syndrome: retrospective analysis of organ damage and mortality. (October 2014) Authors: Dall'Ara, F; Reggia, R; Taraborelli, M; Andreoli, L; Taglietti, M; Frassi, M; Franceschini, F; Tincani, A Journal: Lupus Issue: Volume 23:Number 12(2014) Page Start: 1255 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. PS5:95 Circulating angiogenic t-cells are reduced in patients with systemic lupus erythematosus with high disease activity and without known cardiovascular risk factors. (21st March 2018) Authors: Piantoni, S; Cavazzana, I; Fredi, M; Taraborelli, M; Franceschini, F; Tincani, A; Airo', P Journal: Lupus science & medicine Issue: Volume 5(2018)Supplement 1 Page Start: A84 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Rare autoantibodies to cellular antigens in systemic lupus erythematosus. (June 2014) Authors: Fredi, M; Cavazzana, I; Quinzanini, M; Taraborelli, M; Cartella, S; Tincani, A; Franceschini, F Journal: Lupus Issue: Volume 23:Number 7(2014) Page Start: 672 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Relationship between endothelial dysfunction, videocapillaroscopy and circulating CD3+CD31+CXCR4+ lymphocytes in systemic lupus erythematosus without cardiovascular risk factors. (February 2019) Authors: Cavazzana, I; Piantoni, S; Sciatti, E; Fredi, M; Taraborelli, M; Bonadei, I; Airò, P; Metra, M; Tincani, A; Franceschini, F; Vizzardi, E Journal: Lupus Issue: Volume 28:Number 2(2019) Page Start: 210 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. The contribution of antiphospholipid antibodies to organ damage in systemic lupus erythematosus. (October 2016) Authors: Taraborelli, M; Leuenberger, L; Lazzaroni, M G; Martinazzi, N; Zhang, W; Franceschini, F; Salmon, J; Tincani, A; Erkan, D Journal: Lupus Issue: Volume 25:Number 12(2016) Page Start: 1365 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗